Delivery Order SPE2D020D0014-SPE2D325F8765
Award Date
3/28/25
Potential Completion Date
4/2/25
Potential Value
$2.8K
Federal Agency
Medical Supply Chain
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, to Pfizer Inc. The contract is for the supply of 4 mg/10 ml vials of the opioid overdose reversal drug Naloxone, with a ceiling value of $2,820. The contract is a firm-fixed price arrangement with a period of performance extending through February 27, 2025. This contract is not designated as a small business set-aside. Pfizer is a large, for-profit...
This is a $5,640.00 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of 4,567,312,684 units of 4 mg/10 mL vials of the opioid overdose reversal drug Naloxone. The contract has a period of performance ending on February 24, 2025. This award is not associated with a set-aside program. Pfizer is the prime contractor and no subcontractors are mentioned. The Defense...
This federal contract award, valued at $1,809.60, was issued by the Defense Logistics Agency Troop Support Medical to the prime contractor Pfizer Inc. for the delivery of Naloxone 0.4 mg/mL vials. Naloxone is a medication used to reverse opioid overdose. The contract has an ultimate completion date of April 8, 2025, and is a firm fixed-price delivery order. Pfizer is a large, for-profit pharmaceutical manufacturer that holds significant federal contract vehicles with various government...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical, a defense agency, to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of Naloxone 0.4 mg/ml vials, a critical medication used to reverse opioid overdoses. The contract has a firm fixed price of $1,809.60 and a completion date of December 16, 2024. The contract was awarded without a set-aside designation, reflecting Pfizer's status as a large corporation. As a major...
This federal contract award to Pfizer Inc., valued at $8,460.00, is for the delivery of 4,566,739 vials of 4 mg/10 ml naloxone, an opioid overdose reversal medication. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, without any set-aside designations. Pfizer, a large pharmaceutical manufacturer, is the prime contractor on this delivery order. The contract has an ultimate completion date of December 20, 2024. Pfizer also...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $2,820.00 and is a firm fixed-price contract. The ultimate completion date is April 16, 2025. This contract does not utilize a small business set-aside. Pfizer is a significant prime contractor for the federal government, holding several Indefinite Delivery Vehicle...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $11,280.00 and a completion date of September 24, 2024. This delivery order was awarded without the use of any set-aside designations. Pfizer is a large pharmaceutical corporation that serves as a prime contractor to various federal agencies, providing a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain, a defense agency, to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of 4568256080 NALOXONE 4 MG/10 ML VIAL 10ML. The contract has a ceiling value of $8,460.00 and a period of performance ending on May 20, 2025. The award date is May 15, 2025. This contract is not set-aside for small businesses. Pfizer is an established prime contractor that holds significant federal contract vehicles, including a...
The U.S. Defense Logistics Agency (DLA) awarded a $2,320.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,664,956 units of 4 mg naloxone hydrochloride nasal spray. This order is part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
The federal contract award is for the delivery of 0.4 mg/mL vials of the medication naloxone, a critical drug used to treat opioid overdoses. The contract, valued at $2,132.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. The contract does not have a set-aside designation, indicating it was...